| C. Diff Vaccine |
|
| |
|
| Medical Condition: |
Upcoming Hospitalization or Current/Impending residence in a long-term care facility |
| Facility / Clinic: |
Richmond, VA (NOT conducting in Norfolk) |
| Age: |
40-75 |
| Gender: |
Male or Female |
| Brief Summary: |
National Clinical Research-Richmond is evaluating a vaccine that is designed to protect against C. difficile infection (CDI). CDI is a bacterium that can cause severe gastrointestinal problems. Currently there are no licensed vaccines available that can prevent CDI. |
| Key Inclusion / Exclusion Criteria: |
Have an upcoming hospitalization
OR
Have current/impending residence in a long-term care facility
|
| Enrollment: |
Open |
| Patient Commitment Duration: |
1 - 6 month |
| Patient Compensation: |
You may be reimbursed up to $75 for your participation. |
| Number of Visits in Study: |
3 study visits
|
|
